Carlyle Group Inc. - Q4 2020 holdings

$7.47 Billion is the total value of Carlyle Group Inc.'s 10 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 9.1% .

 Value Shares↓ Weighting
ZI SellZoomInfo Technologies Inc$4,495,871,000
+5.5%
93,217,319
-6.0%
60.21%
+3.8%
PPD  PPD Inc$1,906,832,000
-7.5%
55,722,7330.0%25.54%
-9.0%
ONEM Sell1Life Healthcare Inc$594,194,000
+1.6%
13,612,681
-34.0%
7.96%
-0.0%
LBRT SellLiberty Oilfield Svcs Inc$291,825,000
+7.2%
28,304,996
-16.9%
3.91%
+5.5%
VTRU  Vitru Ltd$92,135,000
+13.6%
6,246,4710.0%1.23%
+11.8%
TALO  Talos Energy Inc$40,870,000
+27.8%
4,960,0000.0%0.55%
+25.5%
ONE  Onesmart Intl Ed Group Ltdsponsored ads$29,868,000
-15.4%
7,860,0000.0%0.40%
-16.8%
DOC  Physicians Rlty Tr$10,464,000
-0.6%
587,8380.0%0.14%
-2.1%
SMHI  Seacor Marine Hldgs Inc$3,111,000
+33.5%
1,147,9890.0%0.04%
+31.2%
SG  Sirius International Insuran$2,177,000
+8.1%
174,1700.0%0.03%
+7.4%
REI ExitRing Energy Inc$0-2,623,948
-100.0%
-0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
eFFECTOR Therapeutics, Inc.August 18, 20234,829,8917.8%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
QuidelOrtho CorpJune 06, 202212,460,18318.6%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
ARS2024-04-18
DEF 14A2024-04-18
DEFA14A2024-04-18
8-K2024-04-03
PRE 14A2024-04-03
42024-04-02
SC 13G2024-03-29
8-K2024-03-27
42024-03-05
SC 13D/A2024-03-05

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings